UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR
REGISTRATION UNDER SECTION 12(b) OF THE
SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 000-50994
BioProgress PLC
NASDAQ Stock Market LLC
(Exact name of Issuer as specified in its charter, and name of Exchange
where security is listed and/or registered)
15-17 Cambridge Science Park
Milton Road, Cambridge CB4 0FQ
UNITED KINGDOM
Telephone number: + 44 (0) 1223 394250
(Address, including zip code, and telephone number, including area code,
of Issuer's principal executive offices)
American Depositary Shares, evidenced by American Depositary Receipts,
each representing ten (10) Ordinary Shares
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to
strike the class of securities from listing and registration:
|_| 17 CFR 240.12d2-2(a)(1)
|_| 17 CFR 240.12d2-2(a)(2)
|_| 17 CFR 240.12d2-2(a)(3)
|_| 17 CFR 240.12d2-2(a)(4)
|_| Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with
its rules to strike the class of securities from listing and/or
withdraw registration on the Exchange.
|X| Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with
the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c)
governing the voluntary withdrawal of the class of securities from
listing and registration on the Exchange.
Pursuant to the requirements of the Securities Exchange Act of 1934, BioProgress
PLC certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing the Form 25 and has caused this notification to be
signed on its behalf by the undersigned duly authorized person.
BIOPROGRESS PLC
/s/ Richard Trevillion
Richard Trevillion
Chief Executive Officer
Dated: June 8, 2007
